Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 661 AL 675

Proteostasis and Neuroinflammation in Alzheimer's Disease

Potokiri A, Wang H.

J Integr Neurosci. 2025 Sep 18;24(9):39826. doi: 10.31083/JIN39826.

Anti-amyloid monoclonal antibody therapies in Alzheimer's disease - a scoping review

Elamin SA, Al Shibli AN, Shaito A, Al-Maadhadi MJMB, Zolezzi M, Pedersen S.

Neuroscience. 2025 Nov 28;589:50-61. doi: 10.1016/j.neuroscience.2025.10.011. Epub 2025 Oct 10.

Alzheimer's Disease: From Molecular Mechanisms to Promising Therapeutic Strategies

Ivanova AV, Kutuzova AD, Kuzmichev IA, Abakumov MA.

Int J Mol Sci. 2025 Sep 26;26(19):9444. doi: 10.3390/ijms26199444.

Microfluidic-Based Technologies for Crossing the Blood-Brain Barrier Against Alzheimer's Disease: Novel Strategies and Challenges

Ferrari I, Limiti E, Giannitelli SM, Trombetta M, Rainer A, D'Amelio M, La Barbera L, Gori M.

Int J Mol Sci. 2025 Sep 27;26(19):9478. doi: 10.3390/ijms26199478.

Advances of therapeutic strategies for Alzheimer's disease

Guo X, Yue R, Cui Z, Wang S, Jia T, Li W, Zhang W, Shan L, Li C.

J Neurol. 2025 Oct 17;272(10):705. doi: 10.1007/s00415-025-13456-8.

Microbial links to Alzheimer's disease

Cornitius CP, Perez EK, Lee SC.

PLoS Pathog. 2025 Oct 23;21(10):e1013599. doi: 10.1371/journal.ppat.1013599. eCollection 2025 Oct.

Cuproptosis: mechanisms and links with Alzheimer's disease

Zheng N, Zhou Q, Chen Z, Xie L, Yang X, Chen Z, Wang F, Sun Q, Du J, Lin J, Li L, Li B.

J Neurophysiol. 2025 Dec 1;134(6):1853-1876. doi: 10.1152/jn.00370.2025. Epub 2025 Oct 27.

A Neural-Glial Model of the ApoE-SORT1-FABP7 Axis Tied to Sleep Disruption and Alzheimer's Disease Pathophysiology

Flores CC, Lee Y, Davis CJ, Solverson P, Gerstner JR.

Biomolecules. 2025 Oct 10;15(10):1432. doi: 10.3390/biom15101432.

From the hive to the brain: synergistic potential of honeybee products with alzheimer's drugs

El-Seedi HR, Salama S, Shetaia AA, Elashal MH, El-Wahed AA, Karav S, Saeed A, Alzahrani MA, Zou X, Hritcu L, Cheng G, Salem MF, Zhong Z, Guo Z, Khalifa SAM.

Metab Brain Dis. 2025 Oct 29;40(8):299. doi: 10.1007/s11011-025-01727-2.

Mitophagy in Alzheimer's disease and its potential as a therapeutic target

Wei J, Xiao T, Lyu J, Zhao Y, Zhang Y, Du X, He Y, Zhao M, Yang X, Yao Y, Ruan J, Liu K, Zhang L, Zhao J, Xu J, Wang B.

Neurobiol Dis. 2025 Dec;217:107162. doi: 10.1016/j.nbd.2025.107162. Epub 2025 Oct 28.

[Research progress in the role of HCN channels in Alzheimer's disease]

Li XJ, Zheng B, Lan P, Zhang WX, Li YP, He Z.

Sheng Li Xue Bao. 2025 Oct 25;77(5):867-875. doi: 10.13294/j.aps.2025.0078.

[Modern therapeutic strategies for the treatment of Alzheimer's disease (literature review).]

Avdeenko TA, Guseinova NM, Dzhafarzade FY, Zagorul'ko AA.

Adv Gerontol. 2025;38(3):441-449.

Six-membered N-heterocyclic alkaloids as ChE inhibitors in alzheimer's disease treatment

Yadav P, Dabas A, Singh R.

Metab Brain Dis. 2025 Nov 6;40(8):309. doi: 10.1007/s11011-025-01740-5.

The Energetic Collapse of the Alzheimer's Brain: Metabolic Inflexibility Across Cells and Networks

Constantino NJ, Ashley CC, Macauley SL.

J Neurochem. 2025 Nov;169(11):e70294. doi: 10.1111/jnc.70294.

Targeted Nanoparticles for Drug Delivery Across the Blood-Brain Barrier in Early and Late Stages of Alzheimer's Disease: A Review

Kochman U, Sitka H, Kuźniar J, Czaja M, Kozubek P, Beszłej JA, Leszek J.

Mol Neurobiol. 2025 Nov 19;63(1):75. doi: 10.1007/s12035-025-05417-z.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias